Loteprednol Etabonate and Tobramycin Articles
Pfizer and B&L to co-promote ophthalmics
9 March 2009
Pharmos gets $12.1M milestone for Zylet launch
7 February 2005
Bausch & Lomb's Zylet OKed in the USA
20 December 2004
Approvable letter for B&L's ophthalmic
16 August 2004
FDA accepts B&L and Pharmos' combo eye filing
10 November 2003
Analyst's Rcommendation For Pharmos
16 December 1996
Showing 1-6 of 6 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
